U.S. Markets closed

PerkinElmer expands prenatal screening test offerings

PerkinElmer announced the first available early onset preeclampsia screening test in the U.S. The PreeclampsiaScreen T1 serum screening test enables physicians to more precisely detect asymptomatic patients in the first trimester of pregnancy who are at high risk for developing the dangerous condition, allowing for earlier identification, management and intervention.